| Name | long intergenic non-protein coding RNA 936 |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n LINC00936, a long intergenic noncoding RNA, exhibits distinct and context‐dependent functions across disease settings. In gastric cancer, reduced levels of LINC00936 correlate with enhanced immune escape of cancer cells. Upregulation of LINC00936 inhibits this immune escape through modulation of the miR‑425‑3p/ZC3H12A axis, which in turn is associated with increased CD3 expression, suggesting a potential role in promoting antitumor immunity."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n In ovarian cancer, LINC00936 functions as a competitive endogenous RNA by binding miR‑221‑3p to regulate the expression of the laminin alpha 3 chain gene (LAMA3). Overexpression of LINC00936 leads to decreased miR‑221‑3p levels and consequent upregulation of LAMA3, thereby suppressing cell proliferation, migration, invasion, angiogenesis, and tumorigenesis."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Conversely, in the context of myocardial infarction, LINC00936 is upregulated, and its overexpression exacerbates myocardial injury by promoting apoptosis and reactive oxygen species accumulation in hypoxic cardiomyocytes. This detrimental effect is mediated via sponging miR‑4795‑3p, which results in increased Wnt3a expression and further aggravation of cardiac cell damage."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n "}]}, {"type": "t", "text": "\n "}, {"type": "p", "children": [{"type": "t", "text": "\n Collectively, these studies highlight that while LINC00936 acts as a tumor suppressor in several cancers by functioning as a ceRNA, its role in myocardial infarction appears to be injurious. This context‐dependent functionality underscores its potential as both a biomarker and a therapeutic target in diverse pathological conditions.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Haohao Li, Chunlin Zhao, Hongchao Zhao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated linc00936 or silenced microRNA-425-3p inhibits immune escape of gastric cancer cells via elevation of ZC3H12A."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int Immunopharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.intimp.2021.107559"}], "href": "https://doi.org/10.1016/j.intimp.2021.107559"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33756228"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33756228"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chenggan Shu, Weiwei Wang, Lipei Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LINC00936/microRNA-221-3p Regulates Tumor Progression in Ovarian Cancer by Interacting with LAMA3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Recent Pat Anticancer Drug Discov (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/1574892817666220316152201"}], "href": "https://doi.org/10.2174/1574892817666220316152201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35297352"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35297352"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Lvyun Xu, Fan Wang "}, {"type": "b", "children": [{"type": "t", "text": "LINC00936 exacerbated myocardial infarction progression via miR-4795-3p/Wnt3a signaling pathway based on biological and imaging methods."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Perfusion (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/02676591221076788"}], "href": "https://doi.org/10.1177/02676591221076788"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35410528"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35410528"}]}]}]}
|
| Synonyms | ATP2B1-AS1 |
| NCBI Gene ID | 338758 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
LINC00936 has 287 functional associations with biological entities spanning 4 categories (chemical, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 11 datasets.
Click the + buttons to view associations for LINC00936 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00936 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00936 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of LINC00936 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of LINC00936 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of LINC00936 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of LINC00936 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of LINC00936 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of LINC00936 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain LINC00936 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of LINC00936 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of LINC00936 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |